Tanja Fauti

Person

Zuerich, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies binding to HLA-A2/MAGE-A4
- Patent number 11,987,632
- Issue date May 21, 2024
- HOFFMANN-LA ROCHE INC.
- Tina Weinzierl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies against CD3EPSILON and ROR1
- Patent number 11,952,421
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies specific for T-cell activating antigens and a...
- Patent number 11,639,397
- Issue date May 2, 2023
- Roche Glycart AG
- Peter Bruenker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tumor-targeted agonistic CD28 antigen binding molecules
- Patent number 11,608,376
- Issue date Mar 21, 2023
- HOFFMANN-LA ROCHE INC.
- Guy Georges
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for the selection of antibodies against BCMA
- Patent number 10,851,171
- Issue date Dec 1, 2020
- ENGMAB SÀRL
- Minh Diem Vu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bispecific T cell activating antigen binding molecules
- Patent number 10,766,967
- Issue date Sep 8, 2020
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies against CD3ϵ and BCMA
- Patent number 10,253,104
- Issue date Apr 9, 2019
- ENGMAB AG
- Minh Diem Vu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fc-free antibodies comprising two fab-fragments and methods of use
- Patent number 10,087,250
- Issue date Oct 2, 2018
- Roche Glycart AG
- Peter Bruenker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies against CD3 and BCMA
- Patent number 10,077,315
- Issue date Sep 18, 2018
- ENGMAB SÀRL
- Minh Diem Vu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for the selection of antibodies against BCMA
- Patent number 9,963,513
- Issue date May 8, 2018
- ENGMAB SÀRL
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20240425616
- Publication date Dec 26, 2024
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES BINDING TO HLA-A2/MAGE-A4
- Publication number 20240383987
- Publication date Nov 21, 2024
- HOFFMANN-LA ROCHE INC.
- Tina Weinzierl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES
- Publication number 20240043535
- Publication date Feb 8, 2024
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES
- Publication number 20230416365
- Publication date Dec 28, 2023
- HOFFMANN-LA ROCHE INC.
- Guy GEORGES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BIS...
- Publication number 20230355754
- Publication date Nov 9, 2023
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20230340160
- Publication date Oct 26, 2023
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES BINDING TO GPRC5D
- Publication number 20220259318
- Publication date Aug 18, 2022
- HOFFMANN-LA ROCHE INC.
- ALEXANDER BUJOTZEK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ICOS ANTIBODIES AND TUMOR-TARGETED ANTIGEN BINDING MOLECULES...
- Publication number 20220098305
- Publication date Mar 31, 2022
- HOFFMANN-LA ROCHE INC.
- Stefan DENGL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies binding to HLA-A2/MAGE-A4
- Publication number 20210230278
- Publication date Jul 29, 2021
- HOFFMANN-LA ROCHE INC.
- Tina Weinzierl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA
- Publication number 20210070873
- Publication date Mar 11, 2021
- ENGMAB SARL
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20200347147
- Publication date Nov 5, 2020
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BIS...
- Publication number 20200306373
- Publication date Oct 1, 2020
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1
- Publication number 20200255521
- Publication date Aug 13, 2020
- ENGMAB SARL
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES
- Publication number 20200199234
- Publication date Jun 25, 2020
- HOFFMANN-LA ROCHE INC.
- Guy GEORGES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20180273643
- Publication date Sep 27, 2018
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA
- Publication number 20180222991
- Publication date Aug 9, 2018
- ENGMAB SARL
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA
- Publication number 20170327579
- Publication date Nov 16, 2017
- ENGMAB AG
- MINH DIEM VU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TR...
- Publication number 20170306044
- Publication date Oct 26, 2017
- MINH DIEM VU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1
- Publication number 20170306018
- Publication date Oct 26, 2017
- MINH DIEM VU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA
- Publication number 20170306036
- Publication date Oct 26, 2017
- ENGMAB AG
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIGEN BINDING MOLECULES
- Publication number 20170198043
- Publication date Jul 13, 2017
- Roche Glycart AG
- Johannes Auer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20170190783
- Publication date Jul 6, 2017
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific T cell activating antigen binding molecules
- Publication number 20170114146
- Publication date Apr 27, 2017
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20170096485
- Publication date Apr 6, 2017
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1
- Publication number 20160297881
- Publication date Oct 13, 2016
- ENGMAB AG
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc-free antibodies comprising two Fab-fragments and methods of use
- Publication number 20160130347
- Publication date May 12, 2016
- Roche Glycart AG
- Peter Bruenker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND BCMA
- Publication number 20150376287
- Publication date Dec 31, 2015
- ENGMAB AG
- Minh Diem VU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA
- Publication number 20150368351
- Publication date Dec 24, 2015
- ENGMAB AG
- Minh Diem VU
- G01 - MEASURING TESTING
Information Patent Application
BISPECIFIC ANTIBODIES SPECIFIC FOR T-CELL ACTIVATING ANTIGENS AND A...
- Publication number 20150274845
- Publication date Oct 1, 2015
- Roche Glycart AG
- Peter Bruenker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20130078249
- Publication date Mar 28, 2013
- Oliver Ast
- C07 - ORGANIC CHEMISTRY

Tanja Fauti

Person

Patents Grantslast 30 patents

Antibodies binding to HLA-A2/MAGE-A4

Bispecific antibodies against CD3EPSILON and ROR1

Bispecific antibodies specific for T-cell activating antigens and a...

Tumor-targeted agonistic CD28 antigen binding molecules

Method for the selection of antibodies against BCMA

Bispecific T cell activating antigen binding molecules

Bispecific antibodies against CD3ϵ and BCMA

Fc-free antibodies comprising two fab-fragments and methods of use

Bispecific antibodies against CD3 and BCMA

Method for the selection of antibodies against BCMA

Patents Applicationslast 30 patents

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

ANTIBODIES BINDING TO HLA-A2/MAGE-A4

IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES

TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES

COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BIS...

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

ANTIBODIES BINDING TO GPRC5D

NOVEL ICOS ANTIBODIES AND TUMOR-TARGETED ANTIGEN BINDING MOLECULES...

Antibodies binding to HLA-A2/MAGE-A4

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BIS...

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1

TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TR...

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

BISPECIFIC ANTIGEN BINDING MOLECULES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Bispecific T cell activating antigen binding molecules

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1

Fc-free antibodies comprising two Fab-fragments and methods of use

BISPECIFIC ANTIBODIES AGAINST CD3 AND BCMA

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

BISPECIFIC ANTIBODIES SPECIFIC FOR T-CELL ACTIVATING ANTIGENS AND A...

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES